United States Biotechnology & Medical Research

Alto Neuroscience Inc (ANRO)

Track

Track

Alto Neuroscience Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred in July 2024, when Chief Medical Officer Adam Savitz acquired shares. Prior to that, various executives and institutional entities executed multiple purchases throughout early 2024, reflecting historical patterns of accumulation by key leadership members.
Ticker: ANRO Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alto Neuroscience Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.9
Savitz Adam CHIEF MEDICAL OFFICER Officer
Transaction date
Purchase
Price
347.61
Quantity 33,919 -0.6%
Value US$550,668
0.9
Savitz Adam CHIEF MEDICAL OFFICER Officer
Transaction date
Purchase
Price
337.44
Quantity 28,862 +35.5%
Value US$2,503,866
0.9
Savitz Adam CHIEF MEDICAL OFFICER Officer
Transaction date
Purchase
Price
167.93
Quantity 92,563 -30.1%
Value US$4,675,034
1.3
Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
16.56
Quantity 4,550 +20.4%
Value US$75,348
1.3
Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
15.80
Quantity 1,600 +7.7%
Value US$25,280
Alpha Wave Global, LP Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 600,000 +19.3%
Value US$9,600,000
1.3
Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
16.00
Quantity 1,563 +inf%
Value US$25,008
0.9
Savitz Adam CHIEF MEDICAL OFFICER Officer
Transaction date
Purchase
Price
16.00
Quantity 17,000 +216.5%
Value US$272,000
Etkin Amit PRESIDENT AND CEO Executive Director
Transaction date
Purchase
Price
16.00
Quantity 3,125 +0.3%
Value US$50,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-11 2024-07-10 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
33,919 -0.6%
347.61
US$550,668 		33,919 -0.6% 347.61 US$550,668
2024-07-11 2024-07-09 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
28,862 +35.5%
337.44
US$2,503,866 		28,862 +35.5% 337.44 US$2,503,866
2024-07-11 2024-07-09 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
92,563 -30.1%
167.93
US$4,675,034 		92,563 -30.1% 167.93 US$4,675,034
2024-04-01 2024-03-28 B Purchase
1.3
Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER

Officer
4,550 +20.4%
16.56
US$75,348 		4,550 +20.4% 16.56 US$75,348
2024-04-01 2024-03-28 B Purchase
1.3
Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER

Officer
1,600 +7.7%
15.80
US$25,280 		1,600 +7.7% 15.80 US$25,280
2024-02-08 2024-02-06 B Purchase
Alpha Wave Global, LP
Large shareholder
600,000 +19.3%
16.00
US$9,600,000 		600,000 +19.3% 16.00 US$9,600,000
2024-02-07 2024-02-06 B Purchase
1.3
Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER

Officer
1,563 +inf%
16.00
US$25,008 		1,563 +inf% 16.00 US$25,008
2024-02-07 2024-02-06 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
17,000 +216.5%
16.00
US$272,000 		17,000 +216.5% 16.00 US$272,000
2024-02-07 2024-02-06 B Purchase
Etkin Amit

PRESIDENT AND CEO

Executive Director
3,125 +0.3%
16.00
US$50,000 		3,125 +0.3% 16.00 US$50,000
Explore more

More insider trading research around Alto Neuroscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America